Qin Zheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Qin Zheng has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
Kai Yang
2 shared publicationsQing Tao
2 shared publicationsWenting Zhu
2 shared publicationsXinhao Wan
2 shared publicationsXuecheng Wang
2 shared publicationsYaqi Wang
2 shared publications
Latest Publications
- Open Access
- 9 October 2026
- Published by Elsevier in SSRN Electronic Journal
Prediction-bias-informed slope and bias correction (SBC) for cross-batch near-infrared quantification during herbal extract concentration
Near-infrared (NIR) spectroscopy offers rapid, nondestructive analysis, but maintaining the predictive performance of quantitative models across new production batches remains a challenge for reliable quality monitoring in complex manufacturing processes. This study developed NIR quantitative models for solid content, narirutin, and hesperidin during the concentration of Jianwei Xiaoshi Tablet extracts. Batches B1–B5, prepared from raw-material batch M1, were used for model development and leave-one-batch-out cross-validation, while B6, prepared from a different raw-material batch (M2), served for independent external validation. Cross-batch predictive performance was compared across different modeling methods, data augmentation, and domain adaptation approaches. Prediction bias was then characterized, and slope and bias correction (SBC) was applied to the model outputs. Most models showed reduced predictive performance on B6, with residual predictive deviation (RPD) values below 3 for all three attributes across all models. For partial least squares regression (PLSR), the root mean square errors of prediction (RMSEPs) for solid content, narirutin, and hesperidin increased by 350%, 89%, and 90%, respectively, on B6 relative to B1–B5. After SBC, the corresponding RMSEPs decreased by 78%, 58%, and 67%. Data augmentation and domain adaptation did not consistently improve external-batch prediction, whereas SBC reduced systematic prediction bias. These findings suggest that prediction-bias-informed model correction can improve the cross-batch applicability of NIR models and inform the future development of online quality monitoring systems integrating model-status assessment with correction as needed.
- 9 October 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessPrediction-bias-informed slope and bias correction (SBC) for cross-batch near-infrared quantification during herbal extract concentration
Near-infrared (NIR) spectroscopy offers rapid, nondestructive analysis, but maintaining the predictive performance of quantitative models across new production batches remains a challenge for reliable quality monitoring in complex manufacturing processes. This study developed NIR quantitative models for solid content, narirutin, and hesperidin during the concentration of Jianwei Xiaoshi Tablet extracts. Batches B1–B5, prepared from raw-material batch M1, were used for model development and leave-one-batch-out cross-validation, while B6, prepared from a different raw-material batch (M2), served for independent external validation. Cross-batch predictive performance was compared across different modeling methods, data augmentation, and domain adaptation approaches. Prediction bias was then characterized, and slope and bias correction (SBC) was applied to the model outputs. Most models showed reduced predictive performance on B6, with residual predictive deviation (RPD) values below 3 for all three attributes across all models. For partial least squares regression (PLSR), the root mean square errors of prediction (RMSEPs) for solid content, narirutin, and hesperidin increased by 350%, 89%, and 90%, respectively, on B6 relative to B1–B5. After SBC, the corresponding RMSEPs decreased by 78%, 58%, and 67%. Data augmentation and domain adaptation did not consistently improve external-batch prediction, whereas SBC reduced systematic prediction bias. These findings suggest that prediction-bias-informed model correction can improve the cross-batch applicability of NIR models and inform the future development of online quality monitoring systems integrating model-status assessment with correction as needed.
- Open Access
- 24 September 2026
- Published by Elsevier in SSRN Electronic Journal
Improving cross-batch prediction of critical physicochemical attributes by slope–bias correction of near-infrared models during herbal extract concentration
Near-infrared (NIR) quantitative models can lose predictive accuracy when batch-induced spectral distribution changes alter the calibration relationship, limiting their cross-batch applicability in complex process matrices. This study investigated the cross-batch generalization and correction of NIR models during the concentration of Jianwei Xiaoshi tablet extracts, using solid content, narirutin, and hesperidin as target physicochemical attributes. Six independent concentration batches were prepared. B1–B5, derived from raw-material batch M1, were used for model development and leave-one-batch-out cross-validation, whereas B6, prepared from a different raw-material batch (M2), served as an independent external validation batch. Partial least squares regression (PLSR), convolutional neural network (CNN), domain-adversarial neural network (DANN), and conditional domain-adversarial network (CDAN) models were evaluated, together with multiplicative–additive perturbation-based data augmentation. All models showed reduced predictive performance on B6 relative to the modeling batches. For PLSR, the RMSEPs for solid content, narirutin, and hesperidin increased by 350%, 89%, and 90%, respectively. Despite this deterioration, the predicted and reference values generally retained linear correlations but showed pronounced slope and intercept deviations, indicating systematic prediction bias. Slope and bias correction (SBC) reduced the corresponding RMSEPs by 78%, 58%, and 67%, respectively. In contrast, domain adaptation and data augmentation did not consistently improve external-batch prediction. These results demonstrate that characterizing cross-batch prediction bias can guide targeted post-correction and improve the transferability of NIR quantitative models under batch variation.
- 24 September 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessImproving cross-batch prediction of critical physicochemical attributes by slope–bias correction of near-infrared models during herbal extract concentration
Near-infrared (NIR) quantitative models can lose predictive accuracy when batch-induced spectral distribution changes alter the calibration relationship, limiting their cross-batch applicability in complex process matrices. This study investigated the cross-batch generalization and correction of NIR models during the concentration of Jianwei Xiaoshi tablet extracts, using solid content, narirutin, and hesperidin as target physicochemical attributes. Six independent concentration batches were prepared. B1–B5, derived from raw-material batch M1, were used for model development and leave-one-batch-out cross-validation, whereas B6, prepared from a different raw-material batch (M2), served as an independent external validation batch. Partial least squares regression (PLSR), convolutional neural network (CNN), domain-adversarial neural network (DANN), and conditional domain-adversarial network (CDAN) models were evaluated, together with multiplicative–additive perturbation-based data augmentation. All models showed reduced predictive performance on B6 relative to the modeling batches. For PLSR, the RMSEPs for solid content, narirutin, and hesperidin increased by 350%, 89%, and 90%, respectively. Despite this deterioration, the predicted and reference values generally retained linear correlations but showed pronounced slope and intercept deviations, indicating systematic prediction bias. Slope and bias correction (SBC) reduced the corresponding RMSEPs by 78%, 58%, and 67%, respectively. In contrast, domain adaptation and data augmentation did not consistently improve external-batch prediction. These results demonstrate that characterizing cross-batch prediction bias can guide targeted post-correction and improve the transferability of NIR quantitative models under batch variation.
- Open Access
- 6 May 2026
- Published by Elsevier in SSRN Electronic Journal
Sanwei Doukou Decoction ameliorate plateau insomnia through the TLR4/MyD88/NF-κB signaling pathway
Ethnopharmacological relevanceSanwei Doukou decoction (SDKD) is a classical Tibetan medicine widely used for plateau insomnia in clinical, yet its underlying mechanism remains unclear.Aim of the studyThis study aims to elucidate the mechanisms of SDKD in alleviating plateau insomnia, focusing on the TLR4/MyD88/NF-κB pathway.Materials and methodsChemical components of SDKD were analyzed by Gas chromatography-mass spectrometry (GC-MS). The mouse model of high-altitude insomnia was established under hypobaric hypoxia. Sleep behaviors were observed in vivo. Inflammatory cytokines and neurotransmitters were detected by ELISA. Oxidative stress markers were measured using biochemical kits. Protein expression was examined by immunohistochemistry and Western blot.ResultsSDKD significantly ameliorated plateau insomnia by shortening sleep latency and prolonging sleep duration. GC-MS identified 36 volatile oil components. SDKD reduced serum TNF-α, IL-6 and IL-1β, and increased GABA and melatonin levels in brain tissue. It also decreased MPO and MDA contents, while elevating SOD, GSH-Px and GSH activities. Immunohistochemistry showed that SDKD alleviated hypoxia-induced brain injury. Western blot revealed that SDKD suppressed overactivation of the TLR4/MyD88/NF-κB pathway and upregulated GABRA1 and GABRG2 expression.ConclusionSDKD exerts anti-insomnia effects via inhibiting inflammation through the TLR4/MyD88/NF-κB pathway, enhancing GABAergic neurotransmission, improving antioxidant capacity, and relieving hypoxic brain damage. These findings confirm the classical clinical application of this prescription in high-altitude sleep disorders.
- 6 May 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessSanwei Doukou Decoction ameliorate plateau insomnia through the TLR4/MyD88/NF-κB signaling pathway
Ethnopharmacological relevanceSanwei Doukou decoction (SDKD) is a classical Tibetan medicine widely used for plateau insomnia in clinical, yet its underlying mechanism remains unclear.Aim of the studyThis study aims to elucidate the mechanisms of SDKD in alleviating plateau insomnia, focusing on the TLR4/MyD88/NF-κB pathway.Materials and methodsChemical components of SDKD were analyzed by Gas chromatography-mass spectrometry (GC-MS). The mouse model of high-altitude insomnia was established under hypobaric hypoxia. Sleep behaviors were observed in vivo. Inflammatory cytokines and neurotransmitters were detected by ELISA. Oxidative stress markers were measured using biochemical kits. Protein expression was examined by immunohistochemistry and Western blot.ResultsSDKD significantly ameliorated plateau insomnia by shortening sleep latency and prolonging sleep duration. GC-MS identified 36 volatile oil components. SDKD reduced serum TNF-α, IL-6 and IL-1β, and increased GABA and melatonin levels in brain tissue. It also decreased MPO and MDA contents, while elevating SOD, GSH-Px and GSH activities. Immunohistochemistry showed that SDKD alleviated hypoxia-induced brain injury. Western blot revealed that SDKD suppressed overactivation of the TLR4/MyD88/NF-κB pathway and upregulated GABRA1 and GABRG2 expression.ConclusionSDKD exerts anti-insomnia effects via inhibiting inflammation through the TLR4/MyD88/NF-κB pathway, enhancing GABAergic neurotransmission, improving antioxidant capacity, and relieving hypoxic brain damage. These findings confirm the classical clinical application of this prescription in high-altitude sleep disorders.
- 10 March 2025
- Published by Elsevier in Phytomedicine
- Vol. 140, 156575
Enhancing temozolomide efficacy in GBM: The synergistic role of chuanxiong rhizoma essential oil
- 10 March 2025
- Published by Elsevier in Phytomedicine
- Vol. 140, 156575
Enhancing temozolomide efficacy in GBM: The synergistic role of chuanxiong rhizoma essential oil
- Open Access
- 30 March 2022
- Published by Editorial CSIC in Grasas y Aceites
- Vol. 73 (1) , e441
A comparative evaluation of chemical composition and antimicrobial activities of essential oils extracted from different chemotypes of Cinnamomum camphora (L.) Presl
The purpose of this study is to determine the chemical composition of the essential oils of Cinnamomum camphora (L.) Presl leaves (CCPL) from 5 different habitats in China by GC-MS, and to evaluate their antimicrobial activities against 3 foodborne pathogens, using a paper disc diffusion method. A total of 30 compounds were identified with a predominance of oxygenated monoterpenes, including linalool (42.65%-96.47%), eucalyptol (39.07%-55.35%) and camphor (26.08%) as well as monoterpene hydrocarbons such as sabinene (6.18%-12.93%) and α-terpineol (8.19%-13.81%). Through cluster analysis, CCPL from 5 different habitats can be well divided into 2 categories. Combining with principal component analysis, the habitats can be better correlated with the chemical constituents of the essential oils. The antimicrobial activities of 5 extracted essential oils against 2 gram-negative bacteria and one gram-positive bacteria were assessed. It showed that the essential oil extracted from the CCPL harvested in Jinxi had the strongest antibacterial property. The results of this study provided basis for resource identification of CCPL and quality difference identification of essential oils. Research on the antibacterial properties of several pathogenic strains has proved its application value as a natural food preservative.
- 30 March 2022
- Published by Editorial CSIC in Grasas y Aceites
- Vol. 73 (1) , e441
Open AccessA comparative evaluation of chemical composition and antimicrobial activities of essential oils extracted from different chemotypes of Cinnamomum camphora (L.) Presl
The purpose of this study is to determine the chemical composition of the essential oils of Cinnamomum camphora (L.) Presl leaves (CCPL) from 5 different habitats in China by GC-MS, and to evaluate their antimicrobial activities against 3 foodborne pathogens, using a paper disc diffusion method. A total of 30 compounds were identified with a predominance of oxygenated monoterpenes, including linalool (42.65%-96.47%), eucalyptol (39.07%-55.35%) and camphor (26.08%) as well as monoterpene hydrocarbons such as sabinene (6.18%-12.93%) and α-terpineol (8.19%-13.81%). Through cluster analysis, CCPL from 5 different habitats can be well divided into 2 categories. Combining with principal component analysis, the habitats can be better correlated with the chemical constituents of the essential oils. The antimicrobial activities of 5 extracted essential oils against 2 gram-negative bacteria and one gram-positive bacteria were assessed. It showed that the essential oil extracted from the CCPL harvested in Jinxi had the strongest antibacterial property. The results of this study provided basis for resource identification of CCPL and quality difference identification of essential oils. Research on the antibacterial properties of several pathogenic strains has proved its application value as a natural food preservative.
- 1 May 2020
- Published by Elsevier in Carbohydrate Polymers
- Vol. 235, 115937
Roles of maltodextrin and inulin as matrix formers on particle performance of inhalable drug nanocrystal-embedded microparticles
- 1 May 2020
- Published by Elsevier in Carbohydrate Polymers
- Vol. 235, 115937
Roles of maltodextrin and inulin as matrix formers on particle performance of inhalable drug nanocrystal-embedded microparticles
- 29 November 2017
- Published by Wiley in Phytotherapy Research
- Vol. 32 (3) , 426-435
The influence and mechanism of ligustilide, senkyunolide I, and senkyunolide A on echinacoside transport through MDCK‐MDR1 cells as blood–brain barrier in vitro model
Efficient transcytosis across the blood–brain‐barrier is an important strategy for accessing drug targets within the central nervous system. Ligusticum chuanxiong Hort. was used as a messenger drug to increase the distribution of drugs in brain tissue in Traditional Chinese Medicine. The present study investigates the transport of echinacoside (ECH) through MDCK‐MDR1 cell and the effects of ligustilide (LIG), senkyunolide A (SENA) and senkyunolide I (SENI) in chuanxiong on its transport. The results indicated that the absorption of ECH was relatively poor in MDCK‐MDR1cells, and was concentration dependent and not saturable. The P‐glycoprotein inhibitor verapamil could significantly increase the transport of ECH. It indicated that the transport mechanism might be passive diffusion as the dominating process with the active transportation mediated mechanism involved. The increased apparent permeability of ECH in A → B direction by ethylenediaminetetraacetic acid‐Na2 suggested that ECH was absorbed via the paracellular route. The transport of ECH in A → B direction significantly increased when co‐administrated with increasing concentrations of LIG, SENI and SENA. Western blot analysis and a decrease in transepithelial electrical resistance during the permeation experiment indicated that LIG, SENI and SENA had enhanced the transport of ECH in the BBB models attribute to down‐regulate the expressions of claudin‐5 and zonula occludens‐1 expression.
- 29 November 2017
- Published by Wiley in Phytotherapy Research
- Vol. 32 (3) , 426-435
The influence and mechanism of ligustilide, senkyunolide I, and senkyunolide A on echinacoside transport through MDCK‐MDR1 cells as blood–brain barrier in vitro model
Efficient transcytosis across the blood–brain‐barrier is an important strategy for accessing drug targets within the central nervous system. Ligusticum chuanxiong Hort. was used as a messenger drug to increase the distribution of drugs in brain tissue in Traditional Chinese Medicine. The present study investigates the transport of echinacoside (ECH) through MDCK‐MDR1 cell and the effects of ligustilide (LIG), senkyunolide A (SENA) and senkyunolide I (SENI) in chuanxiong on its transport. The results indicated that the absorption of ECH was relatively poor in MDCK‐MDR1cells, and was concentration dependent and not saturable. The P‐glycoprotein inhibitor verapamil could significantly increase the transport of ECH. It indicated that the transport mechanism might be passive diffusion as the dominating process with the active transportation mediated mechanism involved. The increased apparent permeability of ECH in A → B direction by ethylenediaminetetraacetic acid‐Na2 suggested that ECH was absorbed via the paracellular route. The transport of ECH in A → B direction significantly increased when co‐administrated with increasing concentrations of LIG, SENI and SENA. Western blot analysis and a decrease in transepithelial electrical resistance during the permeation experiment indicated that LIG, SENI and SENA had enhanced the transport of ECH in the BBB models attribute to down‐regulate the expressions of claudin‐5 and zonula occludens‐1 expression.
- 1 May 2016
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 80, 102-108
Leukemia inhibitory factor promote trophoblast invasion via urokinase-type plasminogen activator receptor in preeclampsia
- 1 May 2016
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 80, 102-108
Leukemia inhibitory factor promote trophoblast invasion via urokinase-type plasminogen activator receptor in preeclampsia